THE TIME TO ACT IS NOW

Hepatitis C Micro-Elimination in drug and alcohol services – a practical framework
(44 minutes, 3 seconds)

Emma and Helen discuss what hepatitis C micro-elimination looks like within the drug and alcohol service setting, and provide examples and tips of initiatives that can help services reach their elimination goal.

Speakers
Emma Lamond, National Improvement Manager, We Are With You
Helen Hampton, Lead Clinical Nurse for Blood Born Virus (BBV), The Royal Cornwall Hospitals NHS Trust
Irfan Chhipa, Gilead Sciences Ltd

Drug and Alcohol Service Standards for Hepatitis C Virus (HCV) and other Blood Borne Viruses (BBV)
(33 minutes, 44 seconds)

Laura and Hayley explain what the eight service standards are for drug and alcohol services when identifying and testing for hepatitis C or other BBVs. Then explore what the practicalities are on the front line to meeting and maintain these standards.

Speakers
Laura Hughes, Hepatitis C Elimination Coordinator, Hep C U Later
Hayley Curran, Hep C Co-ordinator, Mersey Care NHS Foundation Trust
Matt Milner, Gilead Sciences Ltd

Assessment for HCV Treatment: DTS led Models and other Blood Borne Viruses (BBV)
(39 minutes, 53 seconds)

Learn about the shift in policy by NHSE to simplify approaches taken to engage those who are reluctant to consider HCV treatment, and why collaborations between ODNs and DTSs are contributing to support this new policy.

Speakers
Mark Gillyon-Powell, Head of Programme HCV Elimination, NHSE
Tracy Kemp, National Hepatitis C Strategy Lead, Change Grow Live
Christine Taylor, Gilead Sciences Ltd

Testing Events: Targeted strategies to support Micro-Elimination
(41 minutes, 44 seconds)

Hepatitis C Trust representatives share how they are collaborating with DTS to increase testing, and how these tactics supported Havering in becoming the first service to achieve hep c elimination in 2023.

Speakers
Alan Howard, Peer-to-Peer Coordinator, Hepatitis C Trust Hampshire
Sean Caddy, Wessex Clinical Van Coordinator, Inclusion Recovery – Hampshire and Dorset
Isaac Onita, Blood Borne Virus (BBV) Lead, Aspire – Havering
Simon Pooley, Peer Project Manager, Hepatitis C Trust – North East London
Wendy Tivey, Gilead Sciences Ltd

Needs Assessment Programme
(33 minutes, 19 seconds)

Beatrice and Robert discuss how a pilot project at the Barts ODN helped develop and refine the Needs Assessment Programme, and why this programme is vital in reaching the NHSE elimination goal.

Click here to learn more about the Needs Assessment Project and how this is managed in Addiction Service and Needle exchanges/ community pharmacy.

Speakers
Beatrice Emmanouil, Analytics Lead, HCV Elimination NHS England
Robert Hammond, ODN Manager, Barts ODN
Christine Taylor, Gilead Sciences Ltd

Drug Treatment Services providers (DTS) introduction
1 minute, 47 seconds

Representatives of the Hep C Elimination steering committee provide an introduction to the event and the aims from the day.

Speakers:
Debbie Moores, Hepatitis C National Coordinator, Humankind
Jackie Webley, Regional Hepatitis C Coordinator, Change Grow Live
Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow Live
Louise Hansford, South Coordinator, Hep C U Later Programme

At the heart of everything we do: A patient’s story
7 minutes, 32 seconds

Louise, cured from hep C, talks about her journey from diagnosis to treatment and being part of initiatives that achieved micro elimination.

Speakers:
Louise Hansford, NHS Addiction Provider Alliance (APA) / MPFT

Stronger together
7 minutes, 37 seconds

Learn about what Gilead Science are doing to support our commitment to the Hep C Elimination initiative. This video provides an overview of Gilead Sciences strategy, partnerships and activities, and what needs to happen next, to increase the number of hep C patients moving onto treatment.

Speakers:
Peter Smethurst, Business Unit Director, Liver & Emerging Viruses, Gilead Sciences Ltd

Drug treatment services panel discussion – Ask the expert
20 minutes, 29 seconds

A multi-disciplinary panel explore and discuss topics around the hep C treatment services, including engagement of local politicians, sharing of data between services, the impact of COVID-19 on service users and optimisation of access to services in the future.
Facilitated by Rachel Halford, CEO, The Hepatitis C Trust

Expert Panel:
Dean Linzey, BBV Consultant
Professor John Dillon, Professor of Hepatology and Gastroenterology, Ninewells Hospital, University of Dundee
Mark Gillyon-Powell, Head of Programme for Hep C Elimination in England, NHSE
Denise Burridge, Director of Nursing, Change Grow Live (CGL)
Louise Hansford, Hep C Coordinator South, NHS APA (Inclusion) / MPFT
Stuart Smith, Director of Community Services, The Hepatitis C Trusts

Drug treatment services Hep C pathway workshop feedback
14 minutes, 50 seconds

Attendees at the Hep C Elimination workshop event present the outcomes of their collaborative discussions around real-life barriers and opportunities along the service user and provider pathway in the management of hep C.

Speakers:
Dr Prun Bujral, Medical Director, Change Grow Live (Hep C Elimination meeting co-chair)
Timothy Lilley, Patient Access to Care team, Gilead Sciences Ltd
Dean Linzey, BBV Consultant
Danny Morris, Midlands & West Regional Manager – Community Services, The Hepatitis C Trust
Dr Rebecca John, National Hepatitis C Lean, Turning Point
Debbie Moores, National Hepatitis C Coordinator, Humankind

Change Grow Live (CGL) Reading
3 minutes, 43 seconds

An inspirational video from a Drug Treatment Services site, which achieved micro elimination of hep C; Safina Shahin, a Senior Healthcare Assistant, talks about how this was accomplished, and shares some of her best practice tips.

Change Grow Live (CGL) West Kent
4 minutes, 35 seconds

An inspirational video from a Drug Treatment Services site, which achieved micro elimination of hep C. Three members of the team responsible for this achievement; Jo Brown (Cluster Lead Nurse), Tracy Tinley (Substance Misuse RGN) and Linda Foreman (Viral Hepatitis CNS) talk about how they accomplished this.